Natrilix Retard (Indapamide)

Indapamide blocks the reabsorption of sodium and chloride ions in the distal convoluted tubule of the kidney. This promotes water loss, decreases plasma volume, and relaxes peripheral blood vessels, together lowering blood pressure and relieving fluid overload.

The dosage of Natrilix Retard is individualized by the prescribing clinician based on the patient’s condition, response, and renal function. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of indapamide in pregnancy and lactation has not been definitively established. Healthcare providers usually weigh potential benefits against possible risks before prescribing it to pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indapamide is a thiazide‑like diuretic that offers a longer duration of action and a lower incidence of certain metabolic side effects compared with classic thiazides. It is often chosen when clinicians need effective blood‑pressure control combined with modest diuretic activity.

Store Natrilix Retard tablets at room temperature, below 25 °C, in the original packaging. Keep the container tightly closed and protect it from excess moisture and direct sunlight.

Natrilix Retard is taken orally, usually once daily, with or without food as directed by the prescriber. Swallow the tablet whole; do not crush or chew it.

Serious risks include severe dehydration, marked electrolyte disturbances such as low potassium or sodium, acute kidney injury, and rare allergic reactions like angioedema. Patients should seek medical attention if they experience symptoms such as extreme weakness, rapid heartbeat, swelling, or rash.

Individuals with known hypersensitivity to indapamide or other sulfonamide drugs, those with severe renal or hepatic impairment, and patients with uncontrolled electrolyte imbalances should avoid using Natrilix Retard unless a physician determines it is safe.